Vitamin D Deficiency and Dysphagia: Muscle Function, Falls and Swallowing Safety

Vitamin D is widely recognised for its role in calcium metabolism and bone health, but its functions extend substantially into muscle physiology — making it directly relevant to dysphagia management. Vitamin D receptors are expressed in skeletal muscle fibres, and adequate vitamin D signalling is necessary for normal muscle protein synthesis, fast-twitch fibre preservation, and neuromuscular coordination. The muscles of swallowing — the tongue, pharyngeal constrictors, and laryngeal elevators — are no exception.

This article reviews the evidence for vitamin D deficiency as a risk factor for dysphagia and impaired swallowing muscle function, the link between vitamin D, sarcopenia, and falls, supplementation guidance, and monitoring in clinical and care settings.


Vitamin D and Muscle Physiology

Mechanisms of vitamin D action in muscle

Vitamin D exerts both genomic (through the vitamin D receptor in muscle cell nuclei) and non-genomic (rapid membrane signalling) effects on skeletal muscle:

  1. Regulation of muscle protein synthesis: Vitamin D signalling through the nuclear receptor promotes the expression of proteins involved in muscle fibre anabolism, particularly type II (fast-twitch) fibres.

  2. Calcium handling: Vitamin D influences the release of calcium from the sarcoplasmic reticulum — essential for muscle contraction. Low vitamin D impairs contraction efficiency.

  3. Fibre type maintenance: Type II fast-twitch fibre atrophy is the hallmark of sarcopenia and is significantly accelerated by vitamin D deficiency. The swallowing musculature — particularly the geniohyoid and suprahyoid muscles — is predominantly composed of type II fibres.

  4. Myopathy risk: Severe vitamin D deficiency causes a characteristic proximal myopathy with weakness and difficulty with functional movements. Subtle deficiency may produce subclinical weakness insufficient to cause overt myopathy but sufficient to worsen swallowing effort.

Karen Chan and colleagues at the HKU Swallowing Research Laboratory have published work on the nutritional determinants of swallowing muscle health, identifying vitamin D as one of several nutrients with biologically plausible roles in sarcopenic dysphagia pathogenesis.


Prevalence of Vitamin D Deficiency in Dysphagia Populations

Vitamin D deficiency is highly prevalent among the populations most affected by dysphagia:

In Hong Kong specifically, despite subtropical climate, vitamin D deficiency is paradoxically common among older institutionalised adults due to indoor living, sunscreen use, and dietary patterns low in marine foods. This is relevant to local care home and hospital practice.


Vitamin D, Falls, and the Dysphagia Connection

Falls are the most commonly cited non-bone consequence of vitamin D deficiency, and the mechanism is primarily muscular: reduced type II fibre function impairs postural reflexes and balance recovery. The fall–dysphagia connection operates through several pathways:

The NICE guideline CG62 (Falls in Older People) recommends vitamin D supplementation as a standard component of falls prevention in care home settings, which has relevance to dysphagia management programmes in the same settings.


Assessment and Interpretation of Vitamin D Status

Serum 25-hydroxyvitamin D (25-OHD)

The standard marker for vitamin D status is serum 25-hydroxyvitamin D (25-OHD), measured in nmol/L (SI) or ng/mL.

25-OHD levelClassification
< 25 nmol/L (< 10 ng/mL)Severe deficiency
25–50 nmol/L (10–20 ng/mL)Deficiency
50–75 nmol/L (20–30 ng/mL)Insufficiency
> 75 nmol/L (> 30 ng/mL)Sufficient
> 250 nmol/L (> 100 ng/mL)Potential toxicity

For muscle function and falls prevention, most evidence supports a target of > 75–100 nmol/L.

When to screen

All patients with sarcopenic dysphagia, older adults in care home settings, and post-stroke patients should be screened for vitamin D deficiency as a standard component of nutritional assessment.


Supplementation Guidance

Standard dosing for deficiency correction

IndicationRecommended approach
Severe deficiency (< 25 nmol/L)Loading dose: 50,000 IU cholecalciferol weekly × 8 weeks, then maintenance
Deficiency (25–50 nmol/L)800–1,000 IU daily cholecalciferol
Insufficiency (50–75 nmol/L)600–800 IU daily
Prevention in care home residents800 IU daily (NICE CG21 recommendation)

Formulation for dysphagia

Vitamin D supplements are available in:

Combined D + calcium supplementation

Vitamin D supplementation for bone health is often combined with calcium. However, for patients with dysphagia primarily being treated for muscle function rather than bone, calcium supplementation adds complexity without necessarily adding benefit. Discuss with the prescribing physician whether calcium co-supplementation is indicated.


Dietary Sources of Vitamin D in Texture-Modified Diets

Dietary vitamin D is found predominantly in marine foods:

SourceVitamin D per 100 gIDDSI compatibility
Canned salmon500–600 IULevel 4–5
Canned sardines300–400 IULevel 4–5
Egg yolk~37 IU per yolkLevel 4 (blended in)
Fortified milk100 IU / 200 mLLevel 0–4 depending on thickening
Fortified yoghurt (smooth)50–80 IU / 200 gLevel 4

Dietary sources alone are generally insufficient to correct significant deficiency, particularly in older adults and care home residents. Supplementation is typically required alongside optimised dietary intake.


Monitoring

Following initiation of vitamin D supplementation:


Key Takeaways


References

  1. Cichero JAY et al. (2017). Development of International Terminology and Definitions for Texture-Modified Foods and Thickened Fluids Used in Dysphagia Management. Dysphagia. PMID 26315994
  2. IDDSI (2019). Complete IDDSI Framework. https://www.iddsi.org/framework
  3. American Speech-Language-Hearing Association. Adult Dysphagia. https://www.asha.org/practice-portal/clinical-topics/adult-dysphagia/
  4. NICE (2013, updated 2017). Intravenous fluid therapy in adults in hospital (CG162). https://www.nice.org.uk/guidance/cg162